These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21265518)

  • 1. Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology.
    Benigni R; Bossa C
    Chem Rev; 2011 Apr; 111(4):2507-36. PubMed ID: 21265518
    [No Abstract]   [Full Text] [Related]  

  • 2. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
    Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction approaches.
    Benigni R
    Chem Rev; 2005 May; 105(5):1767-800. PubMed ID: 15884789
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictive models for carcinogenicity and mutagenicity: frameworks, state-of-the-art, and perspectives.
    Benfenati E; Benigni R; Demarini DM; Helma C; Kirkland D; Martin TM; Mazzatorta P; Ouédraogo-Arras G; Richard AM; Schilter B; Schoonen WG; Snyder RD; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2009 Apr; 27(2):57-90. PubMed ID: 19412856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure--activity relationship (QSAR) studies of mutagens and carcinogens.
    Benigni R; Giuliani A
    Med Res Rev; 1996 May; 16(3):267-84. PubMed ID: 8727427
    [No Abstract]   [Full Text] [Related]  

  • 6. Exploring structure-activity relationships of mutagens and carcinogens.
    Benigni R
    Prog Clin Biol Res; 1991; 372():59-67. PubMed ID: 1956948
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemical structure of mutagens and carcinogens and the relationship with biological activity.
    Benigni R
    J Exp Clin Cancer Res; 2004 Mar; 23(1):5-8. PubMed ID: 15149144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated approach to assess the domain of applicability of some commercial (Q)SAR models.
    Kulkarni SA; Zhu J
    SAR QSAR Environ Res; 2008; 19(1-2):39-54. PubMed ID: 18311633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic QSAR of aromatic amines: new models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens.
    Benigni R; Bossa C; Netzeva T; Rodomonte A; Tsakovska I
    Environ Mol Mutagen; 2007 Dec; 48(9):754-71. PubMed ID: 18008355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-activity relationship modelling of the carcinogenic risk of nitroso compounds using regression analysis and the TOPS-MODE approach.
    Helguera AM; Pérez-Machado G; Cordeiro MN; Combes RD
    SAR QSAR Environ Res; 2010 Apr; 21(3-4):277-304. PubMed ID: 20544552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of mutagenicity and carcinogenicity using in silico modelling: A case study of polychlorinated biphenyls.
    Vračko M; Bobst S
    SAR QSAR Environ Res; 2015; 26(7-9):667-82. PubMed ID: 26329919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships for the mutagenicity and carcinogenicity of simple and alpha-beta unsaturated aldehydes.
    Benigni R; Passerini L; Rodomonte A
    Environ Mol Mutagen; 2003; 42(3):136-43. PubMed ID: 14556221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-aided analysis of mutagenicity and cell transformation data for assessing their relationship with carcinogenicity.
    Taningher M; Malacarne D; Perrotta A; Parodi S
    Environ Mol Mutagen; 1999; 33(3):226-39. PubMed ID: 10334625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR screening of 70,983 REACH substances for genotoxic carcinogenicity, mutagenicity and developmental toxicity in the ChemScreen project.
    Wedebye EB; Dybdahl M; Nikolov NG; Jónsdóttir SÓ; Niemelä JR
    Reprod Toxicol; 2015 Aug; 55():64-72. PubMed ID: 25797653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A computer system of automated evaluation of structure-activity relationship of chemical mutagens].
    Fu ZD; Gu LJ; Chen WR
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Jan; 27(1):16-8. PubMed ID: 8325171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the electrophilic reaction chemistry involved in covalent DNA binding.
    Enoch SJ; Cronin MT
    Crit Rev Toxicol; 2010 Sep; 40(8):728-48. PubMed ID: 20722585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Commission for Protection Against Environmental Mutagens and Carcinogens. Application of SAR methods to non-congeneric data bases associated with carcinogenicity and mutagenicity: issues and approaches.
    Richard AM
    Mutat Res; 1994 Feb; 305(1):73-97. PubMed ID: 7508549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Commission for Protection Against Environmental Mutagens and Carcinogens. Use of SAR in computer-assisted prediction of carcinogenicity and mutagenicity of chemicals by the TOPKAT program.
    Enslein K; Gombar VK; Blake BW
    Mutat Res; 1994 Feb; 305(1):47-61. PubMed ID: 7508547
    [No Abstract]   [Full Text] [Related]  

  • 19. Nongenotoxic carcinogenicity of chemicals: mechanisms of action and early recognition through a new set of structural alerts.
    Benigni R; Bossa C; Tcheremenskaia O
    Chem Rev; 2013 May; 113(5):2940-57. PubMed ID: 23469814
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure-activity relations: maximizing the usefulness of mutagenicity and carcinogenicity databases.
    Klopman G; Rosenkranz H
    Environ Health Perspect; 1991 Dec; 96():67-75. PubMed ID: 1820281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.